PMID: 23848044
Question: Does oxybutynin hydrochloride cause arrhythmia in children with bladder dysfunction?
Correct Answer: yes

======================= Launch the MCC process =======================
PMID: 23848044
Question: Does oxybutynin hydrochloride cause arrhythmia in children with bladder dysfunction?

----- GPT's initial response -----
GPT is reasoning the answer...


**1. Question Analysis**
- The core question is whether oxybutynin hydrochloride induces arrhythmia in children suffering from bladder dysfunction.
- Key information to identify includes evidence linking oxybutynin use to arrhythmia, specifically changes in the QT interval, within the pediatric population.

**2. Evidence Evaluation**
- The study focused on children admitted to Pediatric Surgery and Pediatric Nephrology Clinics between January 2011 and July 2012.
- It found a significant change in the QT interval associated with oxybutynin use, which is directly linked to an increased risk of cardiac arrhythmia.
- The abstract emphasizes the need for close monitoring of cardiac arrhythmia in children taking oxybutynin, underscoring the observed risks.
- While the study appears to provide relevant and direct evidence, details about sample size, study design, and statistical significance are not provided, which could affect the strength of the conclusions.

**3. Conclusion**
- Based on the provided abstract, there is evidence suggesting that oxybutynin hydrochloride is associated with an increased risk of arrhythmia in children with bladder dysfunction.
- However, without more detailed information on the study's methodology and broader supporting research, the evidence, while suggestive, may not be conclusive.

**4. Final Answer:**
**My final choice is: "yes"**
GPT selected: yes

----- Qwen's initial response -----
Qwen is reasoning the answer...


**1. Question Analysis**  
The question asks whether oxybutynin hydrochloride causes arrhythmia in children with bladder dysfunction. Key points to evaluate:  
- Does the study link oxybutynin use to QT interval changes?  
- Does the study associate QT changes with increased arrhythmias in children?  

**2. Evidence Evaluation**  
The abstract states that oxybutynin use caused significant QT interval prolongation, which the authors explicitly linked to an increase in cardiac arrhythmias in children. The recommendation to monitor children on such drugs for arrhythmia further supports this conclusion. However, the study is a subset analysis with an unclear sample size and methodology (e.g., observational vs. controlled). While QT prolongation is a recognized risk factor for arrhythmias, the abstract does not explicitly report direct observation of arrhythmia events, only an inferred association via QT changes.  

**3. Conclusion**  
The study suggests oxybutynin-induced QT prolongation increases arrhythmia risk, but the evidence is based on a subset analysis with limited details on arrhythmia outcomes. Despite this, the authors directly state that QT changes "increased cardiac arrhythmia," implying a causal link. The answer leans toward "yes," but the studyâ€™s limited scope introduces some uncertainty.  

**4. Final Answer:**  
**My final choice is: "yes"**
Qwen selected: yes

----- Deepseek's initial response -----
DeepSeek is reasoning the answer...

**1. Question Analysis**  
The question asks whether oxybutynin hydrochloride causes arrhythmia in children with bladder dysfunction. Key information to evaluate includes evidence linking oxybutynin to QT interval changes and their association with increased arrhythmia risk in this population.  

**2. Evidence Evaluation**  
The study reports significant QT interval changes in children using oxybutynin, explicitly stating that these changes "increased cardiac arrhythmia." QT prolongation is a well-established risk factor for arrhythmias. While the abstract does not specify the magnitude of arrhythmia incidence or detailed statistical data, it directly associates oxybutynin use with arrhythmia risk. The recommendation for close monitoring underscores clinical concern. However, the evidence is limited to a subset of a larger dataset, and the abstract lacks granular details (e.g., sample size, p-values), slightly weakening its reliability.  

**3. Conclusion**  
The study provides evidence of a plausible causal relationship via QT prolongation and explicitly states arrhythmia risk. While stronger confirmation would require additional data (e.g., arrhythmia event rates), the abstract supports a "yes" answer based on the direct link described.  

**4. Final Answer**  
**My final choice is: "yes"**
DeepSeek selected: yes

Initial consensus: All models selected yes